{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["16"],"submitter":["Auliac JB"],"funding":["astra zeneca"],"pubmed_abstract":["<h4>Background</h4>Few epidemiological data are available on surgically treated Caucasian patients with non-small-cell lung cancers (NSCLCs) harboring epidermal growth factor receptor (<i>EGFR</i>) mutations. The main objective of this study was to describe, in the real-world setting, these patients' incidence, clinical, and tumoral characteristics.<h4>Methods</h4>The participating centers included all consecutive localized non-squamous NSCLC patients undergoing surgery between January 2018 and December 2019 in France. <i>EGFR</i> status was determined retrospectively when not available before surgery.<h4>Results</h4>The study includes 1391 no squamous NSCLC patients from 16 centers; <i>EGFR</i> status was determined before surgery in 692 (49.7%) of the cases and conducted as part of the s"],"journal":["Therapeutic advances in medical oncology"],"pagination":["17588359241236451"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10919127"],"repository":["biostudies-literature"],"pubmed_title":["Resected <i>EGFR</i>-mutated non-small-cell lung cancers: incidence and outcomes in a European population (GFPC Exerpos Study)."],"pmcid":["PMC10919127"],"pubmed_authors":["Swalduz A","Thomas PA","Guisier F","Decroisette C","Le Treut J","Blons H","Curcio H","Lupo Mansuet A","De Chabot G","Chouaid C","Greillier L","Basse V","Huchot E","AlainVegnenegre","Bylicki O","Auliac JB","Wislez M","Moreau D","Falchero L"],"additional_accession":[]},"is_claimable":false,"name":"Resected <i>EGFR</i>-mutated non-small-cell lung cancers: incidence and outcomes in a European population (GFPC Exerpos Study).","description":"<h4>Background</h4>Few epidemiological data are available on surgically treated Caucasian patients with non-small-cell lung cancers (NSCLCs) harboring epidermal growth factor receptor (<i>EGFR</i>) mutations. The main objective of this study was to describe, in the real-world setting, these patients' incidence, clinical, and tumoral characteristics.<h4>Methods</h4>The participating centers included all consecutive localized non-squamous NSCLC patients undergoing surgery between January 2018 and December 2019 in France. <i>EGFR</i> status was determined retrospectively when not available before surgery.<h4>Results</h4>The study includes 1391 no squamous NSCLC patients from 16 centers; <i>EGFR</i> status was determined before surgery in 692 (49.7%) of the cases and conducted as part of the s","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024","modification":"2025-04-04T12:34:46.486Z","creation":"2025-04-04T12:34:46.486Z"},"accession":"S-EPMC10919127","cross_references":{"pubmed":["38455711"],"doi":["10.1177/17588359241236451"]}}